Bispecific Monoclonal Antibody-Based ... - ACS Publications

Subscriber access provided by Northern Illinois University

Article

Bispecific Monoclonal Antibody-based Multi-analyte ELISA for Furaltadone Metabolite, Malachite Green and Leucomalachite Green in Aquatic Products Feng Wang, Hong Wang, Yudong Shen, Yongjun Li, Jie-Xian Dong, Zhenlin Xu, Jinyi Yang, Yuanming Sun, and Zhili Xiao J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.6b03233 • Publication Date (Web): 05 Oct 2016 Downloaded from http://pubs.acs.org on October 5, 2016

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 35

Journal of Agricultural and Food Chemistry

1

Bispecific Monoclonal Antibody-based Multi-analyte ELISA for Furaltadone

2

Metabolite, Malachite Green and Leucomalachite Green in Aquatic Products

3

Feng Wang,† Hong Wang,†* Yu-Dong Shen,† Yong-Jun Li,†‡ Jie-Xian Dong,§

4

Zhen-Lin Xu,† Jin-Yi Yang,† Yuan-Ming Sun† and Zhi-Li Xiao†*

5

† Guangdong Provincial Key Laboratory of Food Quality and Safety, College of

6

Food Science, South China Agricultural University, Guangzhou 510642, China

7

‡ Zhongshan Quality Supervision & Inspection Institute of Agricultural Products,

8

Zhongshan 528403, China

9

§ Department of Entomology and Nematology and UCD Comprehensive Cancer

10

Center, University of California, Davis, California 95616, United States

11

Corresponding Author

12

*(H.

13

[email protected].

14

*(Z.

15

[email protected].

Wang)

L.

Tel:

Xiao)

Tel:

+86

+86

2085283448.

2085283448.

Fax:

Fax:

+86

+86

1

ACS Paragon Plus Environment

2085280270.

E-mail:

2085280270.

E-mail:


16

ABSTRACT

17

A new multi-analyte immunoassay was designed to screen furaltadone metabolite

18

5-morpholinomethyl-3-amino-2-oxazolidone (AMOZ), malachite green (MG), and

19

leucomalachite green (LMG) in aquatic products using a bispecific monoclonal

20

antibody (BsMAb). Gradient drug mutagenesis methods were separately used to

21

prepare an anti-3-nitrobenzaldehyde-derivatized AMOZ (3-NPAMOZ) hybridoma cell

22

line that was hypoxanthine-guanine-phosphoribosyltransferase (HGRPT) deficient

23

and an anti-LMG hybridoma cell line that was thymidine kinase (TK) deficient.

24

BsMAb recognizing 3-NPAMOZ and LMG was generated using hybrid-hybridomas

25

of HGRPT and TK deficient cell lines. For AMOZ and LMG, respectively, the

26

BsMAb-based indirect competitive ELSIA (ic-ELISA) values of 1.7 ng/mL and 45.3

27

ng/mL and detection limits of 0.2 ng/mL and 4.8 ng/mL. To establish the ic-ELISA,

28

3-NPAMOZ derivatized from AMOZ with 3-nitrobenzaldehyde and LMG reduced

29

from MG by potassium borohydride was recognized by BsMAb. Recoveries of

30

AMOZ, MG, and LMG in aquatic products were satisfactory and correlated with

31

HPLC analysis. Thus, the multi-analyte ic-ELISA is suitable for rapid quantification

32

of AMOZ, MG and LMG in aquatic products.

33

KEYWORDS: furaltadone metabolite, malachite green, leucomalachite green,

34

bispecific monoclonal antibody, multi-analyte immunoassay, ELISA

2


Page 2 of 35

Page 3 of 35


35

Introduction

36

Immuno-based assays are helpful and convenient for assuring food safety1-3, and

37

researches indicate that most current immunoassay methods used to identify

38

contaminants are

39

immunoassays are based on polyclonal antibody(PAb), monoclonal antibody (MAb)

40

or recombinant antibody (RAb).7-9 However, most immunoassays could only quantify

41

a single analyte, not multiple contaminants in a complex food matrix.10 Thus, a

42

multi-analyte immunoassay (MAIA) is needed to address this scientific deficit.11,12

rapid,

sensitive,

specific, and inexpensive4-6. Also,

the

43

Bispecific antibodies (BsAb) could be obtained via chemical cross-linking13,14,

44

molecular biology15,16, or hybrid-hybridoma technology17,18. Bispecific monoclonal

45

antibodies (BsMAb) are monoclonals with two different specific antigen-binding sites,

46

normally generated via hybrid-hybridomas.19 BsMAb could specifically bind two

47

different analytes using its two antigen-binding sites, and thus has a clear advantage in

48

analyzing two contaminants. Recently, BsMAb were used for molecular-recognition

49

in high-throughput screening of harmful substances in food products. Jin’s group

50

developed a highly specific BsMAb that could measure both carbofuran and

51

triazophos, and a highly sensitive and rapid enzyme-linked immunosorbent assay

52

(ELISA) using the BsMAb could measure the two residues with detection limits

53

(LOD) of 1.89 ng/mL for carbofuran and LOD of 0.36 ng/mL for triazophos.20

54

Similarly, Guo developed a visual colloidal gold immunochromatographic strip with

55

BsMAb to detect the same pesticides, and their LOD was 32 ng/mL and 4 ng/mL for

56

carbofuran and triazophos, respectively.21 Li established an ELISA method with

57

BsMAb secreted by a trioma LG-D6 cell line, which was prepared using

58

hybrid-hybridoma technology, and this was used to analyze imidacloprid and

59

parathion-methyl.22

Next,

they

created

a

new

chemiluminescent

3


reaction


Page 4 of 35

60

kinetic-resolved MAIA by tagging two haptens of methyl parathion and imidacloprid

61

with horseradish peroxidase (HRP) and alkaline phosphatase (ALP), respectively, to

62

assay both the two pesticide residues (LOD of 0.33 ng/mL for both).23 The developed

63

MAIA assay with a new analytic strategy was more sensitive than Li’s ELISA. Also,

64

Hua prepared a BsMAb secreted by a trioma cell line and used BsMAb-based

65

ic-ELISA to assess organophosphorus pesticides and two neonicotinoid insecticides.24

66

Furaltadone and malachite green (MG) are two veterinary drugs used in

67

aquaculture that are absorbed by aquatic animals and rapidly metabolized to

68

5-morpholinomethyl-3-amino-2-oxazolidone (AMOZ) and leucomalachite green

69

(LMG), respectively (Figure 1).25,26 Researches suggest that these parent compounds

70

and their metabolites could reach toxic levels for humans.27,28 Relevant reports

71

indicate that MG and LMG are also found in aquatic products.29,30 In order to monitor

72

MG, LMG or AMOZ in aquatic products, some instrumental detecting methods such

73

as

74

chromatography-tandem mass spectrometry (LC–MS/MS) and ultra-high performance

75

liquid

76

(UHPLC–HRMS) have been developed.

77

including lateral flow immunoassay, immunosensor, ELISA, etc. have been raised to

78

detect MG, LMG or AMOZ.33-35 These methods reported are all based on

79

monospecific antibodies. However, AMOZ and MG (LMG) are two types of illegal

80

drugs in aquatic products, and we usually need to monitor both of them in the same

81

sample. BsMAb could provide new strategies in multi-residue detection. Based on it,

82

we could develop immunoassays analyzing two or more analytes in one test.

surface-enhanced

chromatography

resonance

coupled

raman

with

high 29,31,32

scattering

resolution

(SERRS),

mass

liquid

spectrometry

Recently, immunological methods

83

In this study, we developed a BsMAb-based multi-analyte ELISA for joint

84

quantitative analysis of AMOZ, MG, and LMG in aquatic products. We first created

4


Page 5 of 35


85

HGRPT- and TK--deficient hybridoma cell lines and fused them. Next, BsMAb was

86

raised, screened, and purified, and a BsMAb-based ELISA was developed to analyze

87

the residues. The sensitivity, specificity, and recovery of the method were evaluated,

88

and the results indicated that,

89

detecting contaminants in complex aquatic matrices.

the multi-analyte ic-ELISA could be applied for

5



90

Materials and methods

91

Reagents and Materials

92

8-Azaguanine,

5-bromo-2’-deoxyuridine,

culture

media

Page 6 of 35

RPMI-1640,

93

hypoxanthine, aminopterin, and thymidine (HAT) medium, hypoxanthine and

94

thymidine

95

3,3’,5,5’-tetramethylbenzidine

96

hydrochloride, and potassium borohydride were purchased from Sigma Chemicals (St.

97

Louis, MO). Hyclone culture medium was obtained from Hyclone (Logan, UT).

98

Gibco fetal calf serum was purchased from Gibco (Grand Island, NY).

(HT)

medium,

polyethylene (TMB),

glycol

2000

3-nitrobenzaldehyde,

(PEG

2000),

hydroxylamine

99

Tween-20, HCl, K2HPO4, NaOH, ethyl acetate, n-hexane, acidic alumina,

100

acetonitrile, dichloromethane, p-toluenesulfonic acid, ammonium acetate, and

101

ammonium hydroxide were obtained from Shanghai Aladdin Bio-Chem Technology

102

Co., Ltd. (Shanghai, China). Horseradish peroxidase-labeled goat anti-mouse IgG

103

(IgG-HRP) was obtained from Boster Biotech Co., Ltd. (Wuhan, China). Polystyrene

104

ELISA plates were purchased from Jiete Biotech Co., Ltd. (Guangzhou, China).

105

Coating antigens AMOZA-OVA and MG-H8-OVA were prepared in our laboratory,

106

and all other organic solvents and chemicals were of analytical grade. Female Balb/c

107

mice (10-week-old, 25-35 g) were fed in the Guangdong Medical Laboratory Animal

108

Centre (Foshan, China).

109

Apparatus

110

First, 500 mg/3 mL Strata-X-C solid phase extraction (SPE) columns were

111

obtained from Phenomenex (Torrance, CA). ELISA plates were washed using a

112

Multiskan MK2 microplate washer (Thermo Scientific, USA). Absorbances were

113

measured on a Multiskan MK3 microplate reader (Thermo Labsystems, USA). A

114

NanoDrop 2000c UV-Vis spectrophotometer was purchased from Thermo Scientific

6


Page 7 of 35


115

(Wilmington, DE). HPLC-MS/MS analysis was performed with a chromatographic

116

system (Alliance, USA) including a Waters 2695 separation module equipped with an

117

auto-sampler and a Waters 2487 dual lambda absorbance detector (Waters, Milford,

118

MA). The HPLC-FLD assay was conducted using a Waters Alliance 2695-2475

119

HPLC system and an Agilent SB-C18 column (150 mm × 4.6 mm, 5 µm particle size)

120

(Agilent Technologies, CA, USA) with a fluorescent detector (Waters, Milford, MA).

121

Screening of HGRPT and TK Deficient Hybridoma Cell Lines

122

Anti-3-NPAMOZ and anti-LMG hybridomas were developed in our laboratory

123

[3-NPAMOZ: 5-morpholino-methyl-3-(3-nitrobenzylidenamino)-2-oxazolidone]. First,

124

8-azaguanine (8-AG) and 5-bromo-2’-deoxyuridine (5-BrdU), were added at different

125

levels to Hyclone culture medium with 20% Gibco fetal calf serum every two weeks,

126

to screen HGRPT-deficient 3-NPAMOZ and TK-deficient LMG cells, respectively.

127

Cell death from HAT medium was identified to obtain deficient hybridoma cell lines

128

in a humidified 5% CO2 incubator at 37 °C. Monoclonal antibody characteristics were

129

analyzed using ic-ELISA before and after drug treatment. Limiting dilution assays

130

were used to purify the two deficient cell lines for tetradoma production.

131

Preparation of Tetradoma Cell Lines and BsMAb

132

HGRPT-deficient 3-NPAMOZ hybridoma cells and TK-deficient LMG

133

hybridoma cells were fused with PEG 2000 to produce tetradoma cell lines according

134

to published methods.36 After 10 days of cell culture, supernatants from all

135

microplates were analyzed by both indirect noncompetitive and indirect competitive

136

ELISA to confirm that BsMAb recognized and bound to 3-NPAMOZ and LMG. After

137

several rounds of cloning with limiting dilutions, tetradoma cell lines stably secreting

138

BsMAb both against 3-NPAMOZ and LMG were obtained. Female Balb/c

139

mouse-induced antibodies were produced for BsMAb which were purified using

7



140

caprylic acid-ammonium sulfate precipitation. The concentration of BsMAb was

141

quantified using a NanoDrop 2000c UV-Vis spectrophotometer and the BsMAb was

142

stored at −20 °C.

143

BsMAb based Indirect Competitive ELISA

144

The ic-ELISA protocol was performed as described previously.37 Briefly, 96-well

145

microtiter plates were coated with 100 µL/well of AMOZA-OVA or MG-H8-OVA in

146

coating buffer (0.05 mol/L of carbonate buffer, pH 9.6) overnight at 37 °C. After

147

washing two times with 300 µL washing buffer (0.05% PBST), 120 µL/well of

148

blocking solution (5% skim milk in PBST) was added to microplate wells and

149

incubated at 37 °C for 3 h in water bath. Plates were dried for 1 h in a 37 °C oven

150

after blocking solution was discarded. Then 50 µL of the standards or sample extracts

151

and 50 µL of BsMAb (appropriate dilution) were successively added to blocked plate

152

and further incubated at 37 °C for 40 min. After five washes with washing buffer, 100

153

µL/well goat anti-mouse IgG-labeled HRP (1:5,000) was immediately added to plates

154

with a 30 min incubation at 37 °C. After five washes, freshly prepared TMB substrate

155

solution (100 µL/well) was added to all the microplate wells for color development at

156

37 °C for 10 min. Enzymatic reaction was halted by adding 50 µL/well of stopping

157

solution (2 mol/L H2SO4). Absorption was measured on a plate reader at 450 nm, and

158

data analysis was performed with a four-parameter equation to generate a sigmoidal

159

curve using Origin 8.5 software.

160

Optimization of ic-ELISA method

161

A checkerboard titration method was used to determine the optimal

162

concentration of coating antigen (AMOZA-OVA or MG-H8-OVA) and BsMAb

163

dilution. To develop a sensitive multi-analyte ELISA variable such as the BsMAb

164

dilution buffer (PB, PBS, PBST, Tris-HCl), competition time (30-50 min), HRP-IgG

8


Page 8 of 35

Page 9 of 35


165

dilution (1:4000 to 1:8000), HRP-IgG incubation time (30-50 min), working buffer

166

for standard analyte (H2O, PB, PBS, PBST), and pH (from 6.0 to 8.4) were rested.

167

IC50 and maximum absorbance (Amax) were obtained from ELISA standard curves,

168

and Amax, IC50 and Amax/IC50 ratio were used to evaluate the ELISA performance.

169

Cross-Reactivity Study

170

Cross-reactivity (CR) for several analogues was studied by comparing IC50

171

values of the optimized competitive ELISA. CRs were calculated as follows: CR (%)

172

= (IC50 of 3-NPAMOZ or LMG / IC50 of analogues) × 100.

173

Preparation of Samples

174

During sample preparation, AMOZ was derivatized with 3-nitrobenzaldehyde to

175

form 3-NPAMOZ for high-affinity binding to BsMAb. However, sample preparation

176

for LMG did not require this step, so sample treatments were developed separately.

177

Grass carp and tilapia were purchased from a local supermarket. After their skins

178

and bones were removed, muscles were weighed and homogenized. For AMOZ

179

analysis in aquatic products, samples were prepared as described in the literature with

180

slight modifications.31 First, 1 g homogenized fish was transferred into 50 mL

181

centrifuge tubes, spiked with several concentrations of AMOZ, and 4 mL deionized

182

water and 0.5 mL of 1 mol/L HCl were mixed with samples. After the addition of 100

183

µL of 10 mmol/L freshly prepared 3-nitrobenzaldehyde in methanol, samples were

184

incubated at 55 °C for 2 h for derivatizing AMOZ and then 5 mL of 0.1 mol/L

185

K2HPO4, 0.4 mL of 1 mol/L NaOH, and 6 mL ethyl acetate were added. Tube contents

186

were mixed vigorously for 5 min and centrifuged (4000 rpm, 10 min). The upper

187

organic layer was removed to 15 mL centrifuge tubes and evaporated to dryness under

188

nitrogen at 45 °C. Finally, the dry residues were reconstituted with 1 mL PBS and

189

mixed with addition of 1 mL n-hexane. Samples were shaken vigorously for 1 min,

9



190

and then the lower supernatant was separated from the mixture by centrifugation

191

(4000 rpm, 10 min) and determined by ic-ELISA and HPLC-MS/MS.

192

According to procedures of Dong’s group38, the pretreatment method for LMG

193

analysis was carried out as follows: 3 g homogenized fish was weighted and

194

transferred into 50 mL centrifuge tubes, spiked with several concentrations of LMG,

195

MG, or LMG-MG mixtures. After the addition of 1 g disodium EDTA, 3 g acidic

196

alumina, and 8 mL acetonitrile, tubes were vigorously vortexed for 30 s. Then 0.5 mL

197

of 20% hydroxylamine hydrochloride, 1 mL of 0.05 mol/L p-toluene sulfonic acid,

198

and 1.5 mL ammonium acetate buffer (0.125 mol/L, pH 4.5) were added, shaken for 5

199

min, and the supernatant was collected by centrifugation (4000 rpm, 10 min). Another

200

4 mL acetonitrile were added to the sediment, and the samples were vigorously

201

vortexed for 2 min and centrifuged again for another 2 min. Finally, supernatants were

202

merged.

203

Then, 1 mL of 0.2 mol/L potassium borohydride was added into supernatant and

204

incubated in the dark for 10 min. Mixture sample was shaken vigorously for 2 min

205

after the addition of 10 mL dichloromethane and centrifuged for 10 min. The lower

206

organic layer was then transferred to another new tube and evaporated to dryness

207

under nitrogen gas at 40 °C. Finally, 2 mL acetonitrile was used to dissolve the

208

residue for clean-up. Strata-X-C SPE columns were pre-activated with 5 mL

209

acetonitrile. Samples were loaded onto columns, 2 mL acetonitrile-ammonium

210

hydroxide (9:1, v/v) was eluted, and eluents were collected, dried under nitrogen. A

211

final dry residue was reconstituted in 1 mL acetonitrile for ic-ELISA and HPLC

212

analysis.

213

Analysis of Samples by ic-ELISA and HPLC

214

For ic-ELISA analysis of AMOZ and LMG, sample extracts were analyzed at

10


Page 10 of 35

Page 11 of 35


215

appropriate dilution. And for HPLC analysis, the extracts was filtered through a

216

0.22-µm microporous membrane prior to use. AMOZ was derivatized to 3-NPAMOZ

217

and HPLC-MS/MS conditions were modified from published reports32 as follows: An

218

Aglient XDB-C18 (4.6 mm × 50 mm, 1.8 µm particle size) column was purchased

219

from Agilent (Santa Clara, CA) with a mobile phase B of acetonitrile and a mobile

220

phase A of 0.1% formic acid (0.25 mL/min) as follows: 0 min, 22% B; 0–6 min,

221

22–99% B; 6–9 min, 99% B; 9–9.1 min, 99–22% B; and 9.1–15 min, 22% B. The

222

injection volume of 5 µL analytes was determined by ESI-MS/MS in a positive mode.

223

For LMG analysis, a conventional HPLC method with a fluorescent detector

224

(HPLC-FLD) was used based on published methods38. Preparative HPLC was

225

performed on an Agilent SB-C18 column (4.6 mm × 150 mm, 5 µm particle size). The

226

isocratic mobile phase was a mixture of acetonitrile and 0.125 mol/L ammonium

227

acetate (7:3, v/v, pH 4.5) with a flow-rate of 1.0 mL/min and an total injection volume

228

of 20 µL sample extract. The FLD excitation wavelength was 265 nm and emission

229

wavelength was 360 nm.

11



230

Results and discussion

231

Drug treatment of hybridomas and preparation of BsMAb

232

To obtain deficient hybridoma cell lines, Figure 2 depicted a gradient drug

233

mutagenesis application as depicted in Methods. The anti-3-NPAMOZ hybridoma cell

234

line was treated as depicted in Methods (5, 10, 20, 40 µg/mL of 8-AG medium for

235

least 8 weeks), and an anti-LMG hybridoma cell line was cultivated as depicted in

236

Methods (25, 50, 100 µg/mL of 5-BrdU medium for least 6 weeks). Deficient cells

237

were confirmed with cell culture in HAT medium. Figure 3 depicted titers of both

238

monoclonal antibodies before and after drug treatment, and no differences were noted

239

between antibodies in either hybridoma cell line before and after drug treatment. An

240

HGRPT-deficient 3-NPAMOZ hybridoma cell line and a TK-deficient LMG

241

hybridoma cell were fused as depicted in Methods and screened with both

242

non-competitive and competitive indirect ELISA.

243

Different concentration of chemical mutagens produces various mutagenic

244

effects on hybridoma cells. If mutagens level is too low, mutagenesis time will last a

245

long time and the biological stability of cells may be decreased, which is

246

disadvantageous to the drug treatment. Conversely, under a high mutagens level,

247

mutagenesis time will be shortened, but it could induce more gene mutations and

248

result in cellular properties loss.

249

Optimization of BsMAb based ic-ELISA

250

Formats of multi-analyte ELISAs normally exist in two ways: antigen-coated

251

ic-ELISA and antibody-coated direct competitive ELISA (dc-ELISA),11 Considering

252

the factors such as stability reduction of coating antibody, inconvenience in

253

preparation of multi tracers, interaction effect of several response signals and others

254

under the dc-ELISA model, we selected ic-ELISA analysis strategy as the ELISA

12


Page 12 of 35

Page 13 of 35


255

format for further study.

256

Firstly, BsMAb was produced and purified as described in Methods, and optimal

257

ic-ELISA conditions for BsMAb and the coating antigen (AMOZA-OVA or

258

MG-H8-OVA) were tested using chessboard titration. Data showed that the

259

AMOZA-OVA at 250 ng/mL and a 1:16000 BsMAb dilution were the optimal

260

combination. For MG-H8-OVA, 500 ng/mL was best, with a 1:8000 dilution of

261

BsMAb was used in future experiments.

262

To optimize the ELISA Amax values, the lowest IC50 value and the highest ratio of

263

Amax/IC50 were studied, and Table 1 summarized the optimization results for ic-ELISA.

264

For AMOZ analysis, it showed that BsMAb dilution in Tris-HCl buffer (pH 7.4),

265

HRP-IgG antibody (1:9000), a competition reaction time of 30 min, an HRP-IgG

266

incubation time of 30 min, and a standard working solution with PB buffer (pH 6.4)

267

was best. For LMG, data depicted that BsMAb dilution in PB buffer (pH 7.4),

268

HRP-IgG antibody (1:5000), a standard dilution PBST buffer (pH 7.0), and the same

269

HRP-IgG incubation time and competition reaction as before were optimal.

270

Sensitivity and specificity of ic-ELISA for AMOZ and LMG

271

Figure 4 showed standard curves of the ic-ELISA for AMOZ and LMG, fit using

272

Origin Pro 8.5 software. As shown in Table 1, the IC50 value of ic-ELISA for

273

3-NPAMOZ was 1.7 ng/mL (Equivalent to AMOZ concentration of 1.30 ng/mL) with

274

a detection limit (LOD, IC10) of 0.2 ng/mL (Equivalent to AMOZ concentration of

275

0.15 ng/mL). And the IC50 value and LOD of ic-ELISA for LMG were 45.3 ng/mL

276

and 4.8 ng/mL. It indicated the established ic-ELISA had high sensitivity and a wide

277

linear range. Ic-ELISA specificity was measured using CR and data showed that

278

(Table 2), there was no obvious CR with the analogues, but there was CR with

279

furaltadone (32.6% of CR) and AMOZ (2.1% of CR). However, furaltadone was

13



280

rapidly metabolized to AMOZ, and the high CR of furaltadone would not affect the

281

performance of ic- ELISA. For BsMAb specificity for LMG analysis, MG, and LCV

282

had low CR (3.3% and 4.8%, respectively). The BsMAb-based ic-ELISA for

283

measuring AMOZ and LMG was highly specific for the tested compounds.

284

Confirmation of drug-spiked aquatic products with ic-ELISA and HPLC

285

Sample matrix effects were studied using standard curves of blank aquatic

286

products. Ic-ELISA standard curves based on blank fish sample extracts at several

287

dilutions were compared with curves generated from working buffers. Ic-ELISA

288

standard curves appeared in Figure 5. The results indicated that a 1:6 dilution with PB

289

(pH 6.4) for AMOZ analysis could eliminate the matrix effect. And sample extraction

290

clean-up by SPE could be directly used to assay LMG with ic-ELISA. Also, the

291

spiked sample extraction of AMOZ, LMG, MG or LMG-MG were measured with

292

HPLC. For instrument validation, AMOZ was measured using HPLC-MS/MS and

293

LMG by HPLC-FLD (See Table 3 and 4). The recovery of AMOZ in grass carp and

294

tilapia ranged from 72.4% to 101.0% with recovery of MG, LMG and MG-LMG

295

ranged from 75.0% to 108.0%, and the coefficient of variation was less than 15%.

296

Figure 6 showed correlation of ic-ELISA and HPLC-MS/MS or HPLC-FLD analysis.

297

Correlation coefficients between the detecttion results of ic-ELISA and HPLC

298

analysis were all over 0.95, which were satisfactory for further research. The analysis

299

results of multi-analyte ic-ELISA were in good agreement with that from HPLC.

300

Compared with other detection methods, including FPIA developed by Yan39,

301

CLEIA by Xu40 and HPLC by Zhu41, the developed multi-analyte ic-ELISA in this

302

study showed lower detection limit, excellent specificity and high recovery. The

303

multi-analyte ic-ELISA was successfully used to analyze AMOZ, MG and LMG in

304

aquatic products with appropriate specificity, recovery, and accuracy.

14


Page 14 of 35

Page 15 of 35


305

As one of the immunological methods, the established method is time-saving,

306

sensitive, specific, and low-cost compared with most instrumental methods,

307

applicable for screening of AMOZ, MG and LMG residues in aquatic products. In

308

addition, using BsMAb as a bispecific bio-recognition element, combined with the

309

pretreatment method of derivatization, we could detect AMOZ, MG and LMG in one

310

microtiter plate, with the same reagents except sample solutions and standards.

311

Therefore, this method is more convenient and rapid over single-analyte

312

immunoassays.

313

The developed ic-ELISA was suited as a tool for rapid multi-residue detection of

314

AMOZ, MG, and LMG, and this established assay could provide references for

315

analyzing small molecular contaminants in foods. Moreover, BsMAb could be applied

316

in new detection strategies for analysis of related contaminant and be studied for a

317

comprehensive analysis of the antibody structure-function relationship.

15



Page 16 of 35

318

Acknowledgments

319

This work was supported by the National Natural Science Foundation of China

320

(31271866),

321

2012CB720803), Science and Technology Planning Project of Guangdong Province

322

(2014A050503059),

323

Guangzhou

324

(S2012010010323, 2014A030311043). We also greatly thank Professor Wen-Tong

325

Gao for his kind help in manuscript revision.

326

Notes

327

The authors declare no competing financial interest.

National

Basic

Research

Program

of

China

(973

Program,

Science and Technology Planning Project of Program of

(2014J4100185),

Guangdong

Natural

16


Science

Foundation

Page 17 of 35


328

References

329

(1) Dzantiev, B. B.; Byzova, N. A.; Urusov, A. E.; Zherdev, A. V.

330

Immunochromatographic Methods in Food Analysis. TrAC-Trend. Anal. Chem,

331

2014, 55: 81-93.

332

(2) Wu, W. H.; Li, J.; Pan, D.; Li, J.; Song, S. P.; Li, Z. X.; Gao, J. M.; Lu, J. X.

333

Gold Nanoparticle-Based Enzyme-Linked Antibody-Aptamer Sandwich Assay

334

for Detection of Salmonella Typhimurium. ACS Appl. Mater. & Interfaces, 2014,

335

6(19): 16974-16981.

336

(3) Albright, V. C.; Hellmich, R.; Coats, J. R. A Review of Cry Protein Detection

337

with Enzyme-Linked Immunosorbent Assays. J. Agric. Food Chem., 2016, 64:

338

2175-2189.

339

(4) Raeisossadati M. J.; Danesh N. M.; Borna F.; Gholamzad M.; Ramezani M.;

340

Abnous K.; Taghdisi S. M. Lateral Flow Based Immunobiosensors for

341

Detection of Food Contaminants. Biosens. Bioelectro., 2016, 86: 235-246.

342

(5) Lathwal S.; Sikes H. D. A Method for Designing Instrument-Free Quantitative

343

Immunoassays. Anal. Chem., 2016, 88(6): 3194-3202.

344

(6) Shan S.; Lai W. H.; Xiong Y. H.; Wei H.; Xu H. Y.;. Novel Strategies to Enhance

345

Lateral Flow Immunoassay Sensitivity for Detecting Foodborne Pathogens. J.

346

Agric. Food Chem., 2015, 63(3):745-753.

347

(7) Esteve-Turrillas, F. A.; Abad-Somovilla, A.; Quiñones-Reyes, G.; Agulló, C.;

348

Mercader, J. V.; Abad-Fuentes, A. Monoclonal Antibody-Based Immunoassays

349

for Cyprodinil Residue Analysis in QuEChERS-Based Fruit Extracts. Food

17



350

Page 18 of 35

Chem., 2015, 187: 530-536.

351

(8) Zikos, C.; Evangelou, A.; Karachaliou, C. E.; Gourma, G.; Blouchos, P.;

352

Moschopoulou, G.; Yialouris, C.; Griffithd, J.; Johnson, G.; Petrou, P.;

353

Kakabakos, S.; Kintzios, S.; Livaniou, E. Commercially Available Chemicals as

354

Immunizing Haptens for the Development of a Polyclonal Antibody

355

Recognizing

356

Chemosphere, 2015, 119: S16-S20.

Carbendazim

and

Other

Benzimidazole-Type

Fungicides.

357

(9) Kavanagh, O.; Elliott, C. T.; Campbell, K. Progress in the Development of

358

Immunoanalytical Methods Incorporating Recombinant Antibodies to Small

359

Molecular Weight Biotoxins. Anal. Bioanal. Chem., 2015, 407: 2749-2770.

360

(10) Yan, X.; Li, H.; Yan, Y.; Su, X. Q. Developments in Pesticide Analysis by

361

Multi-Analyte Immunoassays: A Review. Anal. Methods, 2014, 6: 3543-3554.

362

(11) Zhang, H. Y.; Wang, S.; Fang, G. Z. Applications and Recent Developments of

363

Multi-Analyte Simultaneous Analysis by Enzyme-Linked Immunosorbent

364

Assays. J. Immunol. Methods, 2011, 368: 1-23.

365

(12) Dobosz, P.; Morais, S.; Bonet, E.; Puchades, R.; Maquieira A. Massive Immuno

366

Multiresidue Screening of Water Pollutants. Anal. Chem., 2015, 87(19):

367

9817-9824.

368

(13) Owais, M.; Kazmi, S.; Tufail, S.; Zubair, S. An Alternative Chemical Redox

369

Method for the Production of Bispecific Antibodies: Implication in Rapid

370

Detection of Food Borne Pathogens. PloS one, 2014, 9(3): e91255.

371

(14) Bhattacharya, P.; Fan, J.; Haddad, C.; Essani, A.; Gopisetty, A.; Elshabrawy, H.

18


Page 19 of 35


372

A.; Vasu, C.; Prabhakar, B. S. A Novel Pancreatic β-cell Targeting

373

Bispecific-Antibody (BsAb) can Prevent the Development of Type 1 Diabetes

374

in NOD Mice. Clin. Immunol, 2014, 153(1): 187-198.

375

(15) Chen, M.; Wen, K.; Tao, X. Q.; Xie, J.; Wang, L. M.; Li, Y.; Ding, S. Y.; Jiang,

376

H. Y. Cloning, Expression, Purification and Characterization of a Bispecific

377

Single-Chain Diabody Against Fluoroquinolones and Sulfonamides in

378

Escherichia Coli. Protein Expres Purif., 2014, 100: 19-25.

379

(16) Ramadoss, N. S.; Schulman, A. D.; Choi, S.; Rodgers, D. T.; Kazane, S. A.; Kim,

380

C. H.; Lawson, B. R.; Young, T. S. An Anti-B Cell Maturation Antigen Bispecific

381

Antibody for Multiple Myeloma. J. Am. Chem. Soc., 2015, 137(16): 5288-5291.

382

(17) Zito, A.; Bromuro, C.; Mandili, G.; Chiani, P.; Horenstein, A. L.; Malavasi, F.;

383

Cauda, R.; Cassone, A.; Torosantucci, A. A Murine, Bispecific Monoclonal

384

Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in

385

Candida Species. PloS one, 2016, 11(2): e0148714.

386

(18) Ganguly, A.; Malabadi, R. B.; Loebenberg, R.; Suresh, M. R.; Sunwoo, H. H.

387

Heterosandwich Immunoswab Assay for Dengue Virus Ns1 Antigen Detection.

388

Diagn. Micr. Infec. Dis., 2014, 78(1): 35-39.

389

(19) Byrne, H.; Conroy, P. J.; Whisstock, J. C.; O’Kennedy, R. J. A Tale of Two

390

Specificities: Bispecific Antibodies for Therapeutic and Diagnostic Applications.

391

Trends Biotechnol., 2013, 31(11): 621-632.

19



392

(20) Jin, R. Y.; Guo, Y. R.; Wang, C. M.; Wu, J. X.; Zhu, G. N. Development of a

393

Bispecific Monoclonal Antibody to Pesticide Carbofuran and Triazophos Using

394

Hybrid Hybridomas. J. Food Sci., 2009, 74(1): T1-T6.

395

(21) Guo, Y. R.; Liu, S. Y.; Gui, W. J.; Zhu, G. N. Gold Immunochromatographic

396

Assay for Simultaneous Detection of Carbofuran and Triazophos in Water

397

Samples. Anal. Biochem., 2009, 389(1): 32-39.

398 399

(22) Li, G. Study on Bispecific Monoclonal Antibody to Pesticide Imidacloprid and Parathion-Methyl. Nanjing: Nanjing Agricultural University, 2011: 1-85.

400

(23) Ouyang, H.; Wang, L. M.; Yang, S. J.; Wang, W. W.; Wang, L.; Liu, F. Q.; Fu, Z.

401

F. Chemiluminescence Reaction Kinetics-Resolved Multianalyte Immunoassay

402

Strategy Using a Bispecific Monoclonal Antibody as the Unique Recognition

403

Reagent. Anal. Chem., 2015, 87(5): 2952-2958.

404

(24) Hua, X. D.; Wang, L. M.; Li, G.; Fang, Q. K.; Wang, M. H.; Liu, F. Q.

405

Multi-Analyte Enzyme-Linked Immunosorbent Assay for Organophosphorus

406

Pesticides and Neonicotinoid Insecticides Using a Bispecific Monoclonal

407

Antibody. Anal. Methods, 2013, 5(6): 1556-1563.

408

(25) Cooper, K. M.; Kennedy, D. G. Nitrofuran Antibiotic Metabolites Detected at

409

Parts Per Million Concentrations in Retina of Pigs-A New Matrix for Enhanced

410

Monitoring of Nitrofuran Abuse. Analyst, 2005, 130(4): 466-468.

411 412 413

(26) Srivastava, S.; Sinha, R.; Roy, D. Toxicological Effects of Malachite Green. Aquat. Toxicol., 2004, 66(3): 319-329. (27) Andersson, D. I.; Hughes, D. Microbiological Effects of Sublethal Levels of

20


Page 20 of 35

Page 21 of 35


414 415

Antibiotics. Nat. Rev. Microbiol., 2014, 12(7): 465-478. (28) Stammati, A.; Nebbia, C.; De Angelis, I.; Albo, A. G.; Carletti, M.; Rebecchi, C.;

416

Zampaglioni, F.; Dacasto, M. Effects of Malachite Green (MG) and its Major

417

Metabolite, Leucomalachite Green (LMG), in Two Human Cell Lines. Toxicol.

418

in Vitro, 2005, 19(7): 853-858.

419

(29) Zhang, Y. Y.; Yu, W. S.; Pei, L.; Lai, K. Q.; Rasco, B. A.; Huang, Y. Q. Rapid

420

Analysis of Malachite Green and Leucomalachite Green in Fish Muscles with

421

Surface-Enhanced Resonance Raman Scattering. Food Chem., 2015, 169:

422

80-84.

423

(30) Li, L.; Lin, Z. Z.; Chen, X. M.; Zhang, H. Y.; Lin, Y. D.; Lai, Z. Z.; Huang, Z. Y.

424

Molecularly Imprinted Polymers for Extraction of Malachite Green fom Fish

425

Samples Prior to its Determination by HPLC. Microchim. Acta, 2015, 182(9):

426

1791-1796.

427

(31) Shendy, A. H.; Al-Ghobashy, M. A.; Alla, S. A. G.; Lotfy, H. M. Development

428

and Validation of a Modified QuEChERS Protocol Coupled to LC–MS/MS for

429

Simultaneous Determination of Multi-Class Antibiotic Residues in Honey. Food

430

Chem., 2016, 190: 982-989.

431

(32) Kaufmann, A.; Butcher, P.; Maden, K.; Walker, S.; Widmer, M. Determination

432

of Nitrofuran and Chloramphenicol Residues by High Resolution Mass

433

Spectrometry Versus Tandem Quadrupole Mass Spectrometry. Anal. Chim. Acta,

434

2015, 862, 41-52.

435

(33) Xu N. F.; Li L. Q.; Song S. S.; Xu L. G.; Kuang H.; Xu C. L; Development of a

436

Lateral Flow Immunoassay for the Detection of Total Malachite Green Residues 21



437

in Fish Tissues. Food Agr. Immunol., 2015, 26(6): 870-879.

438

(34) Zhu D.; Li Q. L.; Pang X. M.; Liu Y.; Wang X.; Chen G. A Sensitive

439

Electrochemical Impedance Immunosensor for Determination of Malachite

440

Green and Leucomalachite Green in the Aqueous Environment. Anal. Bioanal.

441

Chem., 2016, 408(20): 5593-5600.

442

(35) Pimpitak U.; Putong S.; Komolpis K.; Petsom A.; Palaga T. Development of a

443

Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assay for

444

Detection of the Furaltadone Metabolite, AMOZ, in Fortified Shrimp Samples.

445

Food chem., 2009, 116(3): 785-791.

446 447

(36) Kufer, P.; Lutterbüse, R.; Baeuerle, P. A. A Revival of Bispecific Antibodies. Trends Biotechnol., 2004, 22(5): 238-244.

448

(37) Yan, X.; Tang, X. J.; Li, H. X.; Sheng, E. Z.; Yang, D. D.; Wang, M. H. Rapid

449

Detection of Four Organophosphorous and Neonicotinoid Toxicants Using

450

Bi-Enzyme Tracer Competitive Enzyme-Linked Immunosorbent Assay. Food

451

Anal. Method., 2014, 7(6): 1186-1194.

452

(38) Dong, J. X.; Xu, C.; Wang, H.; Xiao, Z. L.; Gee, S. J.; Li, Z. F.; Wang, F.; Wu,

453

W. J.; Shen, Y. D.; Yang, J. Y.; Sun, Y. M.; Hammock, B. D. Enhanced Sensitive

454

Immunoassay: Noncompetitive Phage Anti-Immune Complex Assay for the

455

Determination of Malachite Green and Leucomalachite Green. J. Agri. Food

456

Chem., 2014, 62(34): 8752-8758.

457

(39) Yan X. D.; Hu X. Z.; Zhang H. C.; Liu J.; Wang J. P. Direct Determination of

458

Furaltadone Metabolite, 3-Amino-5-Morpholinomethyl-2-Oxazolidinone, in

459

Meats by a Simple Immunoassay. Food Agr. Immunol., 2012, 23(3): 203-215. 22


Page 22 of 35

Page 23 of 35


460

(40) Xu Z. L.; Zhang S. W.; Sun Y. M.; Shen Y. D.; Lei H. T.; Jiang Y. M.; Eremin S.

461

A.; Yang J. Y.; Wang H. Monoclonal Antibody-Based Fluorescence Polarization

462

Immunoassay for High Throughput Screening of Furaltadone and its Metabolite

463

AMOZ in Animal Feeds and Tissues. Comb. Chem. High T. Sc., 2013, 16:

464

494-502.

465

(41) Zhu C. Y.; Wei J.; Dong X. F.; Guo Z. M.; Liu M. Y.; Liang X. M. Fast Analysis

466

of Malachite Green, Leucomalachite Green, Crystal Violet and Leucocrystal

467

Violet in Fish Issue Based on a Modified QuEChERS Procedure. Chinese. J.

468

Chromatogr., 2014, 32(4): 419-425.

469

23



470

Figure Captions

471

Figure 1. Structures of furaltadone, AMOZ, MG and LMG.

472

Figure 2. Protocols for selection of an HGPRT-deficient 3-NPAMOZ hybridoma cell

473

line using 8-AG and a TK-deficient LMG hybridoma cell line with 5-BrdU.

474

Figure 3. Identification of a 3-NPAMOZ hybridoma cell line (A) and an LMG

475

hybridoma cell line (B) before and after drug treatment with 8-AG and 5-BrdU,

476

respectively.

477 478

Figure 4. BsMAb based ic-ELISA standard curves for AMOZ (A) and LMG (B) analysis

(n = 3).

479

Figure 5. Standard curves of ic-ELISA based on buffers and blank fish sample extract

480

with several-fold dilution buffer solutions (n = 3). (A) matrix effect with grass

481

carp extract at 1:2, 1:4, and 1:6 dilutions for AMOZ analysis; (B) matrix effect

482

with tilapia extract at 1:2, 1:4, and 1:6 dilutions for AMOZ analysis; (C) matrix

483

effect with grass carp extract with and without SPE extraction at 1:1 and 1:2

484

dilutions for LMG analysis; (D) matrix effect with tilapia extract with and

485

without SPE extraction at 1:1 and 1:2 dilutions for LMG analysis.

486

Figure 6. Correlations of analysis of spiked samples with ic-ELISA and HPLC (A)

487

samples spiked with AMOZ; (B) samples spiked with LMG; (C) samples spiked

488

with MG; (D) samples spiked with LMG-MG.

24


Page 24 of 35

Page 25 of 35


Table 1. Optimization results of experimental parameters for ic-ELISA ic-ELISA for analyte AMOZa

Parameters

a

LMG

Coating antigen

AMOZA-OVA

MG-H8-OVA

Coating concentration (ng/mL)

250

500

Dilution of BsMAb

1:16000

1:8000

BsMAb dilution buffer

Tris-HCl (pH 7.4)

PB (pH 7.4)

Competition time (min)

30

30

HRP-IgG dilution

1:9000

1:5000

HRP-IgG incubation time (min)

30

30

Working buffer for standard analyte

PB (pH 6.4)

PBST (pH 7.0)

IC50 (ng/mL)

1.7

45.3

LOD (IC10, ng/mL)

0.2

4.8

Linear response range (IC20 - IC80, ng/mL)

0.4-8.3

7.0-291.7

For AMOZ analysis, the target analyte was a stable AMOZ derivative 3-NPAMOZ.

25



Page 26 of 35

Table 2. CR of ic-ELISA for AMOZ and LMG Tested Compounds

IC50 (ng/mL)

CR (%)

Tested Compounds

IC50 (ng/mL)

CR (%)

3-NPAMOZ

1.7

100

Leucomalachite Green (LMG)

45.3

100

Nitrofurazone

>1000

< 0.1

Malachite green (MG)

1372.7

3.3

Nitrofurantoin

>1000

< 0.1

Brilliant Green

>10000

< 0.1

Furaltadone

5.2

32.6

Leucorilliant Green

>10000

< 0.1

Furazolidone

>1000

< 0.1

Crystal Violet (CV)

>10000

< 0.1

Semicarbazide (SEM)

>1000

< 0.1

Leucocrystal Violet (LCV)

943.8

4.8

1-Aminohydantoin (AHD)

>1000

< 0.1

Parafuchsin

>10000

< 0.1

3-Amino-2-oxazolidone (AOZ)

>1000

< 0.1

Methylene Blue

>10000

< 0.1

AMOZ

81.1

2.1

b

>1000

< 0.1

3-NPAHDb

>1000

< 0.1

3-NPAOZb

>1000

< 0.1

>1000

< 0.1

3-NPSEM

3-Nitrobenzaldehyde b

3-NPSEM, 3-NPAHD, 3-NPAOZ were the derivatives of SEM, AHD, AOZ by

3-nitrobenzaldehyde.

26


Page 27 of 35


Table 3. Recovery of AMOZ from spiked samples by ic-ELISA and HPLC-MS/MS ic-ELISA

HPLC-MS/MS

Aquatic

Spiked level

Found±SD c

Recovery±CV d

Found±SD

Recovery±CV

products

(ng/g)

（ng/g）

（%）

（ng/g）

（%）

Grass carp

1

0.83±0.065

83.0±7.8

0.95±0.038

95.0±4.0

2

2.02±0.087

101.0±4.3

1.79±0.057

89.5±3.2

8

6.88±0.19

86.0±2.8

6.52±0.35

81.5±5.4

32

28.72±1.32

89.8±4.6

30.00±1.11

93.8±3.7

1

0.92±0.042

92.0±4.6

0.91±0.033

91.0±3.6

2

1.62±0.10

81.0±6.2

1.97±0.10

98.5±5.1

8

6.85±0.58

85.6±8.5

6.41±0.13

80.1±2.0

32

23.18±1.83

72.4±7.9

30.40±1.92

95.0±6.3

Tilapia

c

SD: sanderd deviation.

d

CV: coefficient of variation.

27



Page 28 of 35

Table 4. Recovery of LMG, MG or MG-LMG from spiked samples by ic-ELISA and HPLC-FLD ic-ELISA Aquatic

Analyte

Spiked

Found±SD

Recovery±CV

Found±SD

Recovery±CV

level (ng/g)

（ng/g）

（%）

（ng/g）

（%）

2

1.70±0.082

85.0±4.8

1.48±0.65

74.0±4.4

5

3.92±0.13

78.4±3.3

4.75±0.34

95.0±7.2

15

13.01±0.87

86.7±6.7

11.42±0.63

76.1±5.5

100

93.14±5.96

93.1±6.4

94.44±4.44

94.4±4.7

2

1.50±0.096

75.0±6.4

1.46±0.031

73.0±2.1

5

4.82±0.21

96.4±4.4

4.55±0.059

91.0±1.3

15

14.21±0.81

94.7±5.7

11.16±0.64

74.4±5.7

100

83.71±7.20

83.7±8.6

108.24±4.22

108.2±3.9

LMG-MG

2

1.60±0.098

80.0±6.1

1.56±0.11

78.0±7.1

（1:1）

5

4.18±0.34

83.6±8.1

4.55±0.11

91.0±2.4

15

16.01±0.54

106.7±3.4

10.89±0.73

72.6±6.7

100

90.59±3.71

90.6±4.1

108.66±9.56

108.7±8.8

2

1.65±0.11

82.5±6.7

1.82±0.086

91.0±4.7

5

4.97±0.22

99.4±4.4

3.64±0.35

72.8±9.6

15

12.01±1.00

80.1±8.3

10.11±0.99

67.4±9.8

100

79.16±3.96

79.2±5.0

84.96±4.59

85.0±5.4

2

1.60±0.085

80.0±5.3

1.59±0.038

79.5±2.4

5

4.25±0.12

85.0±2.8

3.70±0.30

74.0±8.1

15

12.36±1.04

82.4±8.4

10.57±0.94

70.5±8.9

100

94.31±5.85

94.3±6.2

87.51±4.90

87.5±5.6

LMG-MG

2

2.16±0.11

108.0±5.1

2.05±0.13

102.5±6.4

（1:1）

5

3.96±0.32

79.2±8.1

5.08±0.56

101.6±11.0

15

12.16±0.47

81.1±3.9

10.77±0.88

71.8±8.2

100

92.95±1.95

93.0±2.1

82.53±4.87

82.5±5.9

products Grass carp

LMG

MG

Tilapia

HPLC-FLD

LMG

MG

28


Page 29 of 35


Figure 1. Structures of furaltadone, AMOZ, MG and LMG.

29



8-AG 5-BrdU

100 Durg Concentration (µg/mL)

Page 30 of 35

80 60 40 20 0 0

2

4

6

8

Induction Time (week) Figure 2. Protocols for selection of an HGPRT-deficient 3-NPAMOZ hybridoma cell line using 8-AG and a TK-deficient LMG hybridoma cell line with 5-BrdU.

30


Page 31 of 35


3.5 (A)

3.5 (B)

culture supernatants of 3-NPAMOZ cell line 50 ng 3-NPAMOZ+culture supernatants of 3-NPAMOZ cell line culture supernatants of 3-NPAMOZ-HGPRT¯ cell line 50 ng 3-NPAMOZ+culture supernatants of 3-NPAMOZ-HGPRT¯ cell line

3.0

3.0

2.5

2.5

2.0 A450 nm

A450 nm

culture supernatants of LMG cell line 50 ng LMG+culture supernatants of LMG cell line culture supernatants of TK¯-LMG cell line 50 ng LMG+culture supernatants of TK¯-LMG cell line

1.5 1.0

2.0 1.5 1.0

0.5 0.5

0.0 0.0

0

20

40 60 80 100 120 Dilution of culture supernatants

140

0

16

32 48 64 80 96 112 128 Dilution of culture supernatants

Figure 3. Identification of a 3-NPAMOZ hybridoma cell line (A) and an LMG hybridoma cell line (B) before and after drug treatment with 8-AG and 5-BrdU, respectively.

31



(A)

1.0

(B)

1.0 0.8

0.6

0.6

B/B0

B/B0

0.8

Page 32 of 35

0.4

0.4

0.2

0.2

0.0 0.0

0.1

1

10

100

1000

1

Concentration of 3-NPAMOZ (ng/mL)

10

100

1000

Concentration of LMG (ng/mL)

Figure 4. BsMAb based ic-ELISA standard curves for AMOZ (A) and LMG (B) analysis

(n = 3).

32


Page 33 of 35


1.5

PB (pH 6.4)

(A)

Grass carp extract (1:2)

1.5 (B)

PB (pH 6.4)

1.2

Tilapia extract (1:4) Tilapia extract (1:6)

Tilapia extract (1:2)

Grass carp extract (1:4) Grass carp extract (1:6)

A450 nm

A 450 nm

1.2 0.9

0.9

0.6

0.6

0.3

0.3

0.0

0.0

0.1

1

10

100

1000

0.1


1.0 (C)

PBST (pH 7.0) Grass carp extract without SPE extraction Grass carp extract with SPE extraction Grass carp extract with SPE extraction (1:2)

0.6 0.4

0.0

1000

Tilapia extract with SPE extraction (1:2)

1


PBST (pH 7.0)

0.4

0.0 100

1000

0.6

0.2

10

100

Tilapia extract without SPE extraction Tilapia extract with SPE extraction

0.8

0.2

1

10

1.0 (D)

A 450 nm

A 450 nm

0.8

1


10

100

1000


Figure 5. Standard curves of ic-ELISA based on buffers and blank fish sample extract with several-fold dilution buffer solutions (n = 3). (A) matrix effect with grass carp extract at 1:2, 1:4, and 1:6 dilutions for AMOZ analysis; (B) matrix effect with tilapia extract at 1:2, 1:4, and 1:6 dilutions for AMOZ analysis; (C) matrix effect with grass carp extract with and without SPE extraction at 1:1 and 1:2 dilutions for LMG analysis; (D) matrix effect with tilapia extract with and without SPE extraction at 1:1 and 1:2 dilutions for LMG analysis.

33



（ A） AMOZ

300

y= -0.3721+1.154x

32

2

（ B） LMG

y= -2.488+1.046x 2

R = 0.9976

250

HPLC-FLD (ng/g)

HPLC-MS/MS (ng/g)

R = 0.9726 24

16

200 150 100

8

50 0

0 0

8

16

24

0

32

50

350

（ C） MG

350

y= -3.421+1.098x R2= 0.9516

150 100

150 100

0

0 200

2

200

50

150

300

250

50

100

250

R = 0.9589

200

50

200

y=-2.910+1.046x

250

0

150

（ D） LMG-MG

300

HPLC-FLD (ng/g)

300

100

ic-ELISA (ng/g)

ic-ELISA (ng/g)

HPLC-FLD (ng/g)

Page 34 of 35

250

300

0

50

100

150

200

250

300

ic-ELISA (ng/g)

ic-ELISA (ng/g)

Figure 6. Correlations of analysis of spiked samples with ic-ELISA and HPLC (A) samples spiked with AMOZ; (B) samples spiked with LMG; (C) samples spiked with MG; (D) samples spiked with LMG-MG.

34


Page 35 of 35


Table of Contents Graphic

35


Bispecific Monoclonal Antibody-Based ... - ACS Publications

Recommend Documents